Literature DB >> 30661629

The EQ-5D and the EuroQol Group.

Andrew Lloyd1, A Simon Pickard2.   

Abstract

Mesh：

Year:  2019        PMID： 30661629     DOI： 10.1016/j.jval.2018.12.002

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  6 in total

1.  Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?

Authors:  Trishna Bharadia; Jo Vandercappellen; Tanuja Chitnis; Piet Eelen; Birgit Bauer; Giampaolo Brichetto; Andrew Lloyd; Hollie Schmidt; Miriam King; Jennifer Fitzgerald; Thomas Hach; Jeremy Hobart
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-06-22

2.  Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications.

Authors:  K W Miskowiak; L Fugledalen; A E Jespersen; S M Sattler; D Podlekareva; J Rungby; C M Porsberg; S Johnsen
Journal:  Eur Neuropsychopharmacol       Date:  2022-04-14       Impact factor: 5.415

3.  Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.

Authors:  Juan Zhu; Xin-Xin Yan; Cheng-Cheng Liu; Hong Wang; Le Wang; Su-Mei Cao; Xian-Zhen Liao; Yun-Feng Xi; Yong Ji; Lin Lei; Hai-Fan Xiao; Hai-Jing Guan; Wen-Qiang Wei; Min Dai; Wanqing Chen; Ju-Fang Shi
Journal:  Qual Life Res       Date:  2020-09-15       Impact factor: 4.147

4.  Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables.

Authors:  K W Miskowiak; S Johnsen; S M Sattler; S Nielsen; K Kunalan; J Rungby; T Lapperre; C M Porsberg
Journal:  Eur Neuropsychopharmacol       Date:  2021-03-29       Impact factor: 4.600

5.  Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study.

Authors:  Andrea Párniczky; Péter Hegyi; Klementina Ocskay; Márk Félix Juhász; Nelli Farkas; Noémi Zádori; Lajos Szakó; Zsolt Szakács; Andrea Szentesi; Bálint Erőss; Emőke Miklós; Antal Zemplényi; Béla Birkás; Árpád Csathó; István Hartung; Tamás Nagy; László Czopf; Ferenc Izbéki; László Gajdán; Mária Papp; László Czakó; Dóra Illés; Marco V Marino; Antonello Mirabella; Ewa Małecka-Panas; Hubert Zatorski; Yaroslav Susak; Kristina Opalchuk; Gabriele Capurso; Laura Apadula; Cristian Gheorghe; Ionut Adrian Saizu; Ole H Petersen; Enrique de-Madaria; Jonas Rosendahl
Journal:  BMJ Open       Date:  2022-01-04       Impact factor: 2.692

Review 6.  Health-related quality of life in autoimmune hepatitis.

Authors:  Romée Jalm Snijders; Piotr Milkiewicz; Christoph Schramm; Tom Jg Gevers
Journal:  World J Hepatol       Date:  2021-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.